Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors

Neurochemistry International

Volumn 36, Issue 7, 2000, Pages 595-645

  Arias, Hugo Rubén ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; GALANTAMINE; MONOCLONAL ANTIBODY; NEUROTOXIN; NICOTINIC AGENT; NICOTINIC RECEPTOR; PHYSOSTIGMINE; SEROTONIN; SNAKE VENOM;

BINDING AFFINITY; BINDING SITE; CHEMICAL STRUCTURE; ELECTROPHYSIOLOGY; HUMAN; LIGAND BINDING; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; REVIEW;

SERPENTES;

EID: 0034212292     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00154-0     Document Type: Article

References (339)

1. 190 in the α-subunit of the nicotinic acetylcholine receptor. J. Biol. Chem. 264:1989;12666-12672.
2. Ackermann E.J., Ang E.T.-H., Kanter J.R., Tsigelny I., Taylor P. Identification of pairwise interactions in the α-neurotoxin-nicotinic acetylcholine receptor complex through double mutant cycles. J. Biol. Chem. 273:1998;10958-10964.
3. Ackermann E.J., Taylor P. Nonidentity of the α-neurotoxin binding sites on the nicotinic acetylcholine receptor reveales by modification in α-neurotoxin and receptor structures. Biochemistry. 36:1997;12836-12844.
4. Adams M.E., Olivera B.M. Neurotoxins: overview of an emerging research technology. Trends Neurosci. 17:1994;151-155.
5. Addona G.H., Andrews S.H., Cafiso D.S. Estimating the electrostatic potential at the acetylcholine receptor agonist site using power saturation EPR. Biochim. Biophys. Acta. 1329:1997;74-84.
6. Aiken S.P., Sellin L.C., Schmidt J.J., Weinstein S.A., McArdle J.J. A novel peptide toxin from Trimeresurus wagleri acts pre- and post-synaptically to block transmission at the rat neuromuscular junction. Pharmacol. Toxicol. 70:1992;459-462.
7. Akaike A., Ikeda S.R., Brookes N., Pascuzzo G.J., Rickett D.L., Alburquerque E.X. The nature of interactions of pyridostigmine with the nicotinic acetylcholine receptor-ion channel complex. II. Patch clamp studies. Mol. Pharmacol. 25:1984;102-112.
8. Alburquerque E.X., Deshpande S.S., Kawabuchi M., Aracava Y., Idriss M., Rickett D.L., Boyne A.F. Multiple actions of anticholinesterase agents on chemosensitive synapes: molecular basis for prophylaxis and treatment of organophosphate poisoning. Fund. Appl. Toxicol. 5:1985;S182-S203.
9. Alburquerque E.X., Alkondon M., Pereira E.F.R., Castro N.G., Schrattenholz A., Barbosa C.T.F., et al. Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. J. Pharmcol. Exp. Ther. 280:1997;1117-1136.
10. Alkondon M., Alburquerque E.X. Initial characterization of the nicotinic acetylcholine receptors in rat hippocampal neurons. J. Rec. Res. 11:1991;1001-1022.
11. Amin J., Dickerson I.M., Weiss D.S. The agonist binding site of the gamma-aminobutyric acid-type-a channel is not formed by the extracellular cysteine loop. Mol. Pharmacol. 45:1994;317-323.
12. Anand R., Conroy W.G., Schoepfer R., Whiting P., Lindstrom J. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 266:1991;11192-11198.
13. Arias H.R. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor (Review). Mol. Membr. Biol. 13:1996;1-17.
14. Arias H.R. Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Res. Rev. 25:1997;133-191.
15. Arias H.R. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim. Biophys. Acta. 1376:1998;173-220.
16. Arias H.R. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules. J. Neurosci. Res. 52:1998;369-379.
17. Arias, H.R., 1999. Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors. Neurosci. Biobehav. Rev. in press, 1-27.
18. Arias H.R. Neurosci. Biobehav. Rev. 23:1999;817-843.
19. Arias H.R., Valenzuela C.F., Johnson D.A. Transverse localization of the quinacrine binding site on the Torpedo acetylcholine receptor. J. Biol. Chem. 268:1993;6348-6355.
20. Ashcom J.D., Stiles B.G. Characterization of α-conotoxin interactions with the nicotinic acetylcholine receptor and monoclonal antibodies. Biochem. J. 328:1997;245-250.
21. Asher O., Jensen B.S., Lupu-Meiri M., Oron Y., Fuchs S. The mongoose acetylcholine receptor α-subunit: analysis of glycosylation and α-bungarotoxin binding. FEBS Lett. 426:1998;212-216.
22. Aylwin M.L., White M.M. Ligand-receptor interactions in the nicotinic acetylcholine receptor probed using multiple substitutions at conserved tyrosines on the α subunit. FEBS Lett. 349:1994;99-103.
23. Aylwin M.L., White M.M. Gating properties of mutant acetylcholine receptor. Mol. Pharmacol. 46:1994;1149-1155.
24. Balass M., Katchalski-Katzir E., Fuchs S. The α-bungarotoxin bidning site on the nicotinic acetylcholine receptor: Analysis using phage-epitope library. Proc. Natl. Acad. Sci. USA. 94:1997;6054-6058.
25. Barchan D., Kachalsky S., Neumann D., Vogel Z., Ovadia M., Kochva E., Fuchs S. How the mongoose can fight the snake: The binding site of the mongoose acetylcholine receptor. Proc. Natl. Acad. Sci. USA. 89:1992;7717-7721.
26. Barchan D., Ovadia M., Kochva E., Fuchs S. The binding site of the nicotinic acetylcholine receptor in animal species resistant to α-bungarotoxin. Biochemistry. 34:1995;9172-9176.
27. Barnard E.A. The transmitter-gated channels: a range of receptor types and structures. Trends Pharmacol. Sci. 17:1996;305-309.
28. Basus V.J., Song G., Hawrot E. NMR solution structure of an α-bungarotoxin/nicotinic receptor peptide complex. Biochemistry. 32:1993;12290-12298.
29. Bennett J.A., Dingledine R. Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop. Neuron. 14:1995;373-384.
30. Betzel C., Lange G., Pal G.P., Wilson K.S., Maelicke A., Saenger W. The refined crystal structure of α-cobratoxin from Naja naja siamensis at 2.4 Å resolution. J. Biol. Chem. 266:1991;21530-21536.
31. Blount K., Johnson A., Prior C., Marshall I.G. α-Conotoxin GI produces tetanic fade at the rat neuromuscular junction. Toxicon. 30:1992;835-842.
32. Blount P., Merlie J.P. Native folding of an acetylcholine receptor α subunit expressed in the absence of other receptor subunits. J. Biol. Chem. 263:1988;1072-1080.
33. Blount P., Merlie J.P. Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor. Neuron. 3:1989;349-357.
34. 3 receptor. J. Neurochem. 64:1995;1401-1405.
35. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacol. 33:1994;275-317.
36. 3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacol. 36:1997;637-647.
37. Bolger M.B., Dionne V., Chrivia J., Johnson D.A., Taylor P. Interaction of a fluorescent acyldicholine with the nicotinic acetylcholine receptor and acetylcholinesterase. Mol. Pharmacol. 26:1984;57-69.
38. Bon F., Lebrun E., Gomel J., Van Rapenbusch R., Cartaud J., Popot J.-L., Changeux J.-P. Image analysis of the heavy form of the acetylcholine receptor from Torpedo marmorata. J. Mol. Biol. 176:1984;205-237.
39. Brake A.J., Wagenbach M.J., Julius D. New structural motif for ligand-gated ion channels defined by ionotropic ATP receptor. Nature. 371:1994;519-523.
40. Bren N., Sine S.M. Identification of residues in the adult nicotinic acetylcholine receptor that confer selectivity for curariform antagonists. J. Biol. Chem. 272:1997;30793-30798.
41. Brownlee D.J.A., Fairweather Y. Exploring the neurotransmitter labyrinth in nematodes. Trends Neurosci. 22:1999;16-24.
42. Broxton N.M., Down J.G., Gehrmann J., Alewood P.F., Satchell D.G., Livett B.G. α-Conotoxin ImI inhibits the α-bungarotoxin-resistant nicotinic response in bovine adrenal chromaffin cells. J. Neurochem. 72:1999;1656-1662.
43. Bufler J., Kahlert S., Tzartos S., Toyka K.V., Maelicke A., Franke C. Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor. J. Physiol. 492.1:1996;107-114.
44. Bufler J., Pitz R., Czep M., Wick M., Franke C. Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels. Ann. Neurol. 43:1998;458-464.
45. A receptors drastically alter the affinity for ligands of the benzodiazepine binding site. J. Biol. Chem. 272:1997;11799-11804.
46. Canti C., Bodas E., Marsal J., Solsona C. Tacrine and physostigmine block nicotinic receptors in Xenopus oocytes injected with Torpedo electroplaque membranes. Eur. J. Pharmacol. 363:1998;197-202.
47. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. A new α-conotoxin wich targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271:1996;7522-7528.
48. Changeux J.-P., Edelstein S.J. Allosteric receptors after 30 years. Neuron. 21:1998;959-980.
49. Changeux J.-P., Podleski T., Wofsy L. Affinity labeling of the acetylcholine-receptor. Proc. Natl. Acad. Sci. USA. 58:1967;2063-2070.
50. Chatrenet B., Trémeau O., Bontems F., Goeldner M.P., Hirth C.G., Ménez A. Topographical studies of toxin-antibody and toxin-acetylcholine receptor complexes using photoactivatable toxin derivatives. Proc. Natl. Acad. Sci. USA. 87:1990;3378-3382.
51. Chaturvedi V., Donnelly-Roberts D.L., Lentz T.L. Substitution of Torpedo acetylcholine receptor α1-subunit residues with snake α1- and rat nerve α3-subunit residues in recombinant fusion protein: Effect on α-bungarotoxin binding. Biochemistry. 31:1992;1370-1375.
52. Chavez R.A., Hall Z.W. The transmembrane topology of the amino terminus of the alpha subunit of the nicotinic acetylcholine receptor. J. Biol. Chem. 266:1992;15532-15538.
53. Chen J., Zhang Y., Akk G., Sine S., Auerbach A. Activation kinetics of recombinant mouse nicotinic acetylcholine receptors: mutations of α subunit tyrosine 190 affect both binding and gating. Biophys. J. 69:1995;849-859.
54. Chiappinelli V.A., Weaver W.R., McLane K.E., Conti-Fine B.M., Fiordalisi J.J., Grant G.A. Binding of native κ-neurotoxins and site-directed mutants to nicotinic acetylcholine receptors. Toxicon. 34:1996;1243-1256.
55. Chiara D.C., Cohen J.B. Identification of amino acids contributing to high and low affinity d-tubocurarine sites in the Torpedo nicotinic acetylcholine receptor. J. Biol. Chem. 272:1997;32940-32950.
56. 3H]nicotine photoincorporation in the γ-subunit of the Torpedo nicotinic acetylcholine receptor. FEBS Lett. 423:1998;223-226.
57. Chiara D.C., Xie Y., Cohen J.B. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: Affinity-labeling and mutational anlayses identify γTyr-111/δArg-113 as antagonist affinity determinants. Biochemistry. 38:1999;6689-6698.
58. Clark J.H., Martínez-Carrión M. Labeling of functionally sensitive sulfhydryl-containing domains of the actylcholine receptor from Torpedo californica membranes. J. Biol. Chem. 261:1986;10063-10072.
59. Clarke P.B.S., Reuben M., El-Bizri H. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat stratium. Br. J. Pharmacol. 111:1994;695-702.
60. Codignola A., McIntosh J.M., Cattaneo M.G., Vicentini L.M., Clementi F., Sher E. α-Conotoxin Imperialis I inhibits nicotine-evoked hormone release and cell proliferation in human neuroendocrine carcinoma cells. Neurosci. Lett. 206:1996;53-56.
61. Cohen B.N., Figl A., Quick M.W., Labarca C., Davidson N., Lester H.A. Regions of β2 and β4 responsible for differences between the steady state dose-response relationship of the α3β2 and α3β4 neuronal nicotinic receptors. J. Gen. Physiol. 105:1995;745-764.
62. 3H]Acetylcholine mustard identifies residues in the cation-binding subsite. J. Biol. Chem. 266:1991;23354-23364.
63. Conti-Fine B.M., Lei S., McLane K.E. Antibodies as tools to study the structure of membrane proteins: The case of the nicotinic acetylcholine receptor. Annu. Rev. Biophys. Biomol. Struct. 25:1996;197-229.
64. Conti-Fine B.M., Maelicke A., Reinhardt-Maelicke S., Chiappinelli V., McLane K.E. Binding sites for neurotoxins and cholinergic ligands in peripheral and neuronal nicotinic receptors. Studies with synthetic receptor sequences. Ann. N.Y. Acad. Sci. 757:1995;133-152.
65. Conti-Tronconi B.M., Diethelm B.M., Wu X., Tang F., Bertazzon T., Schröder B., Reinhardt-Maelicke S., Maelicke A. α-Bungarotoxin and the competing antibody WF6 interact with different amino acids within the same cholinergic subsite. Biochemistry. 30:1991;2575-2584.
66. Conti-Tronconi B.M., McLane K.E., Raftery M.A., Grando S.A., Protti M.P. The nicotinic acetylcholine receptor: Structure and autoimmune pathology. Crit. Rev. Mol. Biol. 29:1994;69-123.
67. Conti-Tronconi B.M., Tang F., Diethelm B.M., Spencer S.R., Reinhardt-Maelicke S., Maelicke A. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and α-bungarotoxin. Biochemistry. 29:1990;6221-6230.
68. Corringer P.-J., Bertrand S., Bohler S., Edelstein S.J., Changeux J.-P., Bertrand D. Critical elements determining diversity in agonist binding and desensitization of neuronal nicotinic acetylcholine receptors. J. Neurosci. 18:1998;648-657.
69. Corringer P.-J., Galzi J.-L., Eiselé J.-L., Bertrand S., Changeux J.-P., Bertrand D. Identification of a new component of the agonist binding site of the nicotinic α7 homooligomeric receptor. J. Biol. Chem. 270:1995;11749-11752.
70. Criado M., Sarin V., Fox J.L., Lindstrom J. Evidence that the acetylcholine binding site is not formed by the sequence α127-143 of the acetylcholine receptor. Biochemistry. 25:1986;2839-2846.
71. Cross K.M.L., Formena R.C., Chad J.E. Enhancement by 5-hydroxytryptamine and analogues of desensitization of neuronal and muscle nicotinic receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 114:1995;1636-1640.
72. Croxen R., Newland C., Beeson D., Oosterhuis H., Chauplannaz G., Vincent A., Newsom-Davis J. Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum. Mol. Gen. 6:1997;767-774.
73. Czajkowski C., Kaufmann C., Karlin A. Negatively charged amino acid residues in the nicotinic receptor delta subunit that contribute to the binding of acetylcholine. Proc. Natl. Acad. Sci. USA. 90:1993;6285-6289.
74. Czajkowski C., Karlin A. Agonist binding site of Torpedo electric tissue nicotinic acetylcholine receptor. A negatively charged region of the δ subunit within 0.9 nm of the α subunit binding site disulfide. J. Biol. Chem. 266:1991;22603-22612.
75. Czajkowski C., Karlin A. Structure of the nicotinic receptor acetylcholine-binding site. J. Biol. Chem. 270:1995;3160-3164.
76. Damle V.N., Karlin A. Affinity labeling of one of two α-neurotoxin binding sites in acetylcholine receptor from Torpedo californica. Biochemistry. 17:1978;2039-2045.
77. Damle V.N., Karlin A. Effects of agonists and antagonists on the reactivity of the binding site disulfide in acetylcholine receptor from Torpedo californica. Biochemistry. 19:1980;3924-3932.
78. Damle V.N., McLaughlin M., Karlin A. Bromoacetylcholine as an affinity label of the acetylcholine receptor from Torpedo californica. Biochem. Biophys. Res. Commun. 84:1978;845-851.
79. A receptor subtypes: which, where and why? Semin. Neurosci. 7:1995;115-126.
80. Dewan J., Grant G.A., Sacchettini J.C. Crystal structure of κ-bungarotoxin at 2.3-Å resolution. Biochemistry. 33:1994;13147-13154.
81. diPaola M., Czajkowski C., Karlin A. The sidedness of the COOH terminus of the acetylcholine receptor δ-subunit. J. Biol. Chem. 264:1989;1-7.
82. Dougherty D.A. Cation-π interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science. 271:1996;163-167.
83. Dougherty D.A., Stauffer D.A. Acetylcholine binding by a synthetic receptor: implications for biological recognition. Science. 250:1990;1558-1560.
84. Dunn S.M., Conti-Tronconi B.M., Raftery M.A. A high-affinity for acetylcholine ocurrs close to the α-γ subunit interface of Torpedo nicotinic acetylcholine receptor. Biochemistry. 32:1993;8616-8621.
85. Dunn S.M., Raftery M.A. Cholinergic binding sites on the pentameric acetylcholine receptor of Torpedo californica. Biochemistry. 32:1993;8608-8615.
86. Eiselé J.-L., Bertrand S., Galzi J.-L., Devillers-Thiéry A., Changeux J.-P., Bertrand D. Chimeric nicotinic-serotonergic receptor combines distinct ligand binding and channel especificities. Nature. 366:1993;479-483.
87. Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., Heinemann S. α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 79:1994;705-715.
88. Endo T., Tamiya N. Structure-function relationships of postsynaptic neurotoxins from snake venoms. Harvey A.L. Snake Toxins. 1991;165-222 Pergamon Press, New York.
89. Fainzilber M., Hasson A., Oren R., Burlingame A.L., Gordon D., Spira M.E., Zlotkin E. New mollusc-specific α-conotoxins block Aplysia neuronal acetylcholine receptors. Biochemistry. 33:1994;9523-9529.
90. Fairclough R.H., Finer-Moore J., Love R.A., Kristofferson D., Desmeules P.J., Stroud R.M. Subunit organization and structures of an acetylcholine receptor. Cold Spring Harbor Symp. Quant. Biol. 48:1983;9-20.
91. Fairclough R.H., Josephs R., Richman D.P. Imaging ligand binding sites on the Torpedo acetylcholine receptor. Ann. N.Y. Acad. Sci. 681:1993;113-125.
92. Favreau P., Krimm Y., Le Gall F., Bobenrieth M.-J., Lamthanh H., Bouet F., et al. Biochemical characterization and nuclear magnetic resonance structure of novel αconotoxins isolated from the venom of Conus consors. Biochemistry. 38:1999;6317-6326.
93. Fels G., Plümer-Wilk R., Schreiber M., Maelicke A. A monoclonal antibody interfereing with binding and response of the acetylcholine receptor. J. Biol. Chem. 261:1986;15746-15754.
94. Fernández J.M., Granja R., Izaguirre V., González-García C., Ceña V. ω-Conotoxin GVIA blocks nicotine-induced catecholamine secretion by blocking the nicotinic receptor-actived inward currents in bovine chromaffin cells. Neurosci. Lett. 191:1995;59-62.
95. Figl A., Cohen N.B., Quick M.W., Davidson N., Lester H. Regions of β4.β2 subunit chimeras that contribute to the agonist selectivity of neuronal nicotinic receptors. FEBS Lett. 3:1992;243-248.
96. Fiordalisi J.J., Al-Rabiee R., Chiappinelli V.A., Grant G. Site-directed mutagenesis of κ-bungarotoxin: implications for neuronal receptor specificity. Biochemistry. 33:1994;3872-3877.
97. Fu D.-X., Sine S.M. Competitive antagonists bridge the α-γ subunit interface of the acetylcholine receptor through quaternary ammonium-aromatic interactions. J. Biol. Chem. 269:1994;26152-26157.
98. Fulpius B.W., Miskin R., Reich E. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors. Proc. Natl. Acad. Sci. USA. 77:1980;4326-4330.
99. Galzi J.-L., Bertrand S., Corringer P.J., Changeux J.-P., Bertrand D. Identification of calcium binding site that regulate potentiation of a neuronal nicotinic acetylcholine receptor. EMBO J. 15:1996;5824-5832.
100. Galzi J.-L., Revah F., Bouet F., Ménez A., Goeldner M., Hirth C., Changeux J.-P. Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand. Proc. Natl. Acad. Sci. USA. 88:1991;5051-5055.
101. Galzi J.-L., Bertrand D., Devillers-Thiéry A., Revah F., Bertrand S., Changeux J.-P. Functional significance of aromatic amino acids from three peptide loops of the α7 neuronal nicotinic receptor site investigated by site-directed mutagenesis. FEBS Lett. 294:1991;198-202.
102. Galzi J.-L., Revah F., Black D., Goeldner M., Hirth C., Changeux J.-P. Identification of a novel amino acid α-Tyr 93 within the cholinergic ligand-binding sites of the acetylcholine receptor by photoaffinity labeling: additional evidence for a three-loop model of the cholinergic ligand-binding sites. J. Biol. Chem. 265:1990;10430-10437.
103. Gehle V.M., Walcott E.C., Nishizaki T., Sumikawa K. N-Glycosylation at the conserved sites ensures the expression of properly folded functional ACh receptors. Mol. Brain Res. 45:1997;219-229.
104. Gehrmann J., Alewood P.F., Craik D.J. Structure determination of the three disulfide bond isomers of α-conotoxin GI: a model for the role of disulfide bonds in structural stability. J. Mol. Biol. 278:1998;401-415.
105. Gershoni J.M. Expression of the α-bungarotoxin binding site of the nicotinic acetylcholine receptor by Escherichia coli transformants. Proc. Natl. Acad. Sci. USA. 84:1987;4318-4321.
106. Gershoni J.M., Hawrot E., Lentz T.L. Binding of α-bungarotoxin to isolated α subunit of the acetylcholine receptor of Torpedo californica: quantitative analysis with protein blots. Proc. Natl. Acad. Sci. USA. 80:1983;4973-4977.
107. Goldberg G., Mochly-Rosen D., Fuchs S., Lass Y. Monoclonal antibodies modify acetylcholine induced ion channel properties in cultured chick myoballs. J. Membr. Biol. 76:1983;123-128.
108. Gouda H., Yamazaki K., Hasegawa J., Kobayashi Y., Nishiuchi Y., Sakakibara S., Hirono S. Solution structure of α-conotoxin MI determined by H-1-NMR spectroscopy and molecular dynamics simulation with the explicit solvent water. Biochim. Biophys. Acta. 1243:1997;327-334.
109. Grant G.A., Al-Rabiee R., Xu X.L., Zhang Y. Critical interactions at the dimer interface of κ-bungarotoxin, a neuronal nicotinic acetylcholine receptor antagonist. Biochemistry. 36:1997;3353-3358.
110. Grant G.A., Luetje C.W., Summers R., Xu X.L. Differential roles for disulfide bonds in the structural integrity and biological activity of κ-bungarotoxin, a neuronal nicotinic receptor antagonist. Biochemistry. 37:1998;12166-12171.
111. Green W.N., Wanamaker C.P. Formation of the nicotinic acetylcholine receptor binding sites. J. Neurosci. 18:1998;5555-5564.
112. Greismann G.E., McCormick D.J., De Aizpurua H.J., Lennon V.A. α-Bungarotoxin binds to human acetylcholine receptor α-subunit peptide 185-199 in solution and solid phase but not to peptides 125-147 and 389-409. J. Neurochem. 54:1990;1541-1547.
113. Groebe D.R., Dumm J.M., Abramson S.N. Irreversible inhibition of nicotinic acetylcholine receptors by the bipinnatins: Toxin activation and kinetics of receptor inhibition. J. Biol. Chem. 269:1994;8885-8891.
114. Groebe D.R., Dumm J.M., Levitan E.S., Abramson S.N. α-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors. Mol. Pharmacol. 48:1995;105-111.
115. Groebe D.R., Gray W.R., Abramson S.N. Determinants involved in the affinity of α-conotoxins GI and SI for the muscle subtype of the nicotinic acetylcholine receptors. Biochemistry. 36:1997;6469-6474.
116. Gu Y., Forsayeth J.R., Verrall S., Yu X.M., Hall Z.W. Assembly of the mammalian muscle acetylcholine receptor in transfected COS cells. J. Cell Biol. 114:1991;799-807.
117. Guddat L.W., Martin J.A., Shan L., Edmundson A.B., Gray W.R. Three-dimensional structure of the α-conotoxin GI at 1.2 Å resolution. Biochemistry. 35:1996;11329-11335.
118. 3 receptor expressed in Xenopus oocytes. Neurosci. Lett. 247:1998;107-110.
119. Hamilton S.L., Pratt D.R., Eaton D.C. Arrangement of the subunits of the nicotinic acetylcholine receptor from Torpedo californica as determined by α-neurotoxin cross-linking. Biochemistry. 24:1985;2210-2219.
120. A-conotoxin PIVA. Biochemistry. 34:1997;1669-1677.
121. Hann R.M., Pagán O.R., Eterovic V.A. The α-conotoxins GI and MI distinguish between the nicotinic acetylcholine receptor agonist sites while SI does not. Biochemistry. 33:1994;14058-14063.
122. Hann R.M., Pagán O.R., Gregory L.M., Jácome T., Eterovic V.A. The 9-arginine residue of α-conotoxin GI is responsible for its selective high affinity for the αγ agonist site on the electric organ acetylcholine receptor. Biochemistry. 36:1997;9051-9056.
123. Harvey S.C., McIntosh J.M., Cartier G.E., Maddox F.N., Luetje C.W. Determinants of specificity for α-conotoxin MII on α3β2 neuronal nicotinic receptors. Mol. Pharmacol. 51:1997;336-342.
124. Harvey S.C., Luetje C.W. Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits. J. Neurosci. 16:1996;3798-3806.
125. Heidmann T., Changeux J.-P. Fast kinetic studies on the interaction of a fluorescent agonist with the membrane-bound acetylcholine receptor from Torpedo marmorata. Eur. J. Biochem. 94:1979;255-279.
126. Hervé M., Pillet L., Humbert P., Trémeau O., Ducanel F., Hirth C., Ménez A. Role and environment of conserved Lys27 of snake curaremimetic toxins as probed by chemical modifications, site-directed mutagenesis and photolabelling experiments. Eur. J. Biochem. 208:1992;125-131.
127. Herz J.M., Johnson D.A., Taylor P. Distance between the agonist and the noncompetitive inhibitor sites on the nicotinic acetylcholine receptor. J. Biol. Chem. 264:1989;12439-12448.
128. Holtzman E., Wise D., Wall J., Karlin A. Electron microscopy of complexes of isolated acetylcholine receptor, biotynil-toxin, and avidin. Proc. Natl. Acad. Sci. USA. 79:1982;310-314.
129. Hopkins C., Grilley M., Miller C., Shon K.-J., Cruz L.J., Gray W.R., et al. A new family of Conus peptides targeted to the nicotinic acetylcholine receptor. J. Biol. Chem. 270:1995;22361-22367.
130. Horne W.A., Hawrot E., Tsien R.W. ω-Conotoxin GVIA receptors of discopyge electric organ. Characterization of ω-conotoxin binding to the nicotinic acetylcholine receptor. J. Biol. Chem. 266:1991;13719-13725.
131. Hu S.-H., Gehrmann J., Guddat L.W., Alewood P.F., Craik D.J., Martin J.L. The 1.1 Å crystal structure of the neuronal acetylcholine receptor antagonist, α-conotoxin PnIA from Conus pennaceus. Structure. 4:1996;417-423.
132. Hucho F., Tsetlin V.I., Machold J. The emerging three-dimensional structure of a receptor. The nicotinic acetylcholine receptor. Eur. J. Biochem. 239:1996;539-557.
133. Huganir R.L., Greengard P. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron. 5:1990;555-567.
134. Hussy N., Ballivet M., Bertrand D. Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by α-subunits and β-subunits. J. Neurophysiol. 72:1994;1317-1326.
135. Ikari H., Spangler E.L., Greig N.H., Pei X.-F., Brossi A., Speer D., et al. Maze learning in aged rats is enhanced by phenserine, a novel anticholinesterase. NeuroReport. 6:1995;481-484.
136. Jacobsen R., Yoshikami D., Ellison M., Martínez J., Gray W.R., Cartier G.E., et al. Differential targeting of nicotinic acetylcholine receptors by novel αA-conotoxins. J. Biol. Chem. 272:1997;22531-22537.
137. Jackson M.B. Perfection of a synaptic receptor: the kinetics and energetics of the acetylcholine receptor. Proc. Natl. Acad. Sci. USA. 86:1989;2199-2203.
138. Johnson D.A., Cushman P., Malekzadeh R. Orientation of α-toxin on the surface of the nicotinic acetylcholine receptor: a fluorescent spectroscopic study. J. Biol. Chem. 265:1990;7360-7368.
139. Johnson D.A., Nuss J.M. The histrionicotoxin-sensitive ethidium binding site is located outside of the transmembrane domain of the nicotinic acetylcholine receptor: a fluorescence study. Biochemistry. 33:1994;9070-9077.
140. Johnson D.A., Voet J.G., Taylor P. Fluorescence energy transfer between cobra α-toxin molecules bound to the acetylcholine receptor. J. Biol. Chem. 259:1984;5717-5725.
141. Johnson D.S., Martínez J., Elgoyhen A.B., Heinemann S.F., McIntosh J.M. α-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric α7 and α9 receptors. Mol. Pharmacol. 48:1995;194-199.
142. Jones M.V., Westbrook G.L. The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci. 19:1996;96-101.
143. Kachalsky S.G., Aladjem M., Barchan D., Fuchs S. The ligand binding domain of the nicotinic acetylcholine receptor. Immunological analysis. FEBS Lett. 318:1993;264-268.
144. Kachalsky S.G., Jensen B.S., Barchan D., Fuchs S. Two subsites in the binding domain of the acetylcholine receptor: An aromatic subsite and a proline subsite. Proc. Natl. Acad. Sci. USA. 92:1995;10801-10805.
145. 3H]-dopamine release from rat striatal synaptosomes and slices. J. Neurochem. 70:1998;1069-1076.
146. Kang S., Maelicke A. Fluorescein isothiocyanate-labeled alpha-cobratoxin: biochemical characterization and interaction with acetylcholine receptor from Electrophorus electricus. J. Biol. Chem. 256:1980;7326-7332.
147. Kao P.N., Karlin A. Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues. J. Biol. Chem. 261:1986;8085-8088.
148. Karlin A., Akabas M.H. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron. 15:1995;1231-1244.
149. Kasheverov Y., Zhmak M., Chivilyov E., Saezbrionez P., Utkin Y., Hucho F., Tsetlin V. Benzophenone-type photoactivatable derivatives of α-neurotoxins and α-conotoxins in studies on Torpedo nicotinic acetylcholine receptor. J. Rec. Signal Transd. Res. 19:1999;559-571.
150. Kehoe J.-S., McIntosh J.M. Two distinct nicotinic receptors, one pharmacologically similar to the vertebrate α7-containing receptor, mediate Cl currents in Aplysia neurons. J. Neurosci. 18:1998;8198-8213.
151. Keller S.H., Kreienkamp H.-J., Kawanishi C., Taylor P. Molecular determinants conferring α-toxin resistence in recombinant dNA-derived acetylcholine receptors. J. Biol. Chem. 270:1995;4165-4171.
152. Keyser K.T., Britto L.R.G., Schoepfer R., Whitting P., Cooper J., Conroy W., et al. Three subtypes of α-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J. Neurosci. 13:1993;442-454.
153. Khakh B.S., Bao X.R., Labarca C., Lester H.A. Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nature Neurosci. 2:1999;322-330.
154. Kistler J., Stroud R.M., Klymkowsky M.W., Lalancette R.A., Fairclough R.H. Structure and function of an acetylcholine receptor. Biophys. J. 37:1982;371-383.
155. Kreienkamp H.-J., Maeda R.K., Sine S.M., Taylor P. Intersubunit contacts governing assembly of the mammalian nicotinic acetylcholine receptor. Neuron. 14:1995;635-644.
156. Kreienkamp H.-J., Sine S.M., Maeda R.K., Taylor P. Glycosylation sites selectively interfere with α-toxin binding to the nicotinic acetylcholine receptor. J. Biol. Chem. 269:1994;8108-8114.
157. Kreienkamp H.-J., Utkin Y.N., Weise C., Machold J., Tsetlin V.I., Hucho F. Investigation of ligand-binding sites of the acetylcholine receptor using photoactivatable derivatives of neurotoxin II from Naja naja oxiana. Biochemistry. 31:1992;8239-8244.
158. 3 receptor subunit. J. Biol. Chem. 274:1999;3934-3936.
159. Kuhlmann J., Okonjo K.O., Maelicke A. Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel. FEBS Lett. 279:1991;216-218.
160. Kulak J.M., Nguyen T.A., Olivera B.M., McIntosh J.M. α-Conotoxin MII blocks nicotine-stimulated release in rat striatal synaptosomes. J. Neurosci. 17:1997;5263-5270.
161. Kuner T., Wollmuth L.P., Karlin A., Seeburg P.H., Sakmann B. Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines. Neuron. 17:1996;343-352.
162. Langosch D., Becker C.-M., Betz H. The inhibitory glycine receptor: a ligand-gated chloride channel of the central nervous system. Eur. J. Biochem. 194:1990;1-8.
163. Laube B., Kuhse J., Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18:1998;2954-2961.
164. Lee Y.-H., Li L., Lasalde J., Rojas L., McNamee M.G., Ortiz-Miranda S.I., Pappone P. Mutations in the M4 domain of Torpedo californica acetylcholine receptor dramatically alter ion channel function. Biophys. J. 66:1994;646-653.
165. Le Novère N., Changeux J.-P. Molecular evolution of the nicotinic
166. Le Novère N., Corringer P.-J., Changeux J.-P. Improved secondary structure predictions from a nicotinic receptor subunit: Incorporation of solvent accessibility and experimental data into a two-dimensional representation. Biophys. J. 76:1999;2329-2345.
167. Lentz T.L. Differential binding of nicotine and α-bungarotoxin to residues 173-204 of the nicotinic acetylcholine receptor α1-subunit. Biochemistry. 34:1995;1316-1322.
168. Lentz T.L., Chaturvedi V., Conti-Fine B.M. Amino acids within residues 181-200 of the nicotinic acetylcholine receptor α1 subunit involved in nicotine binding. Biochem. Pharmacol. 55:1998;341-347.
169. Lester R.A.J., McIntosh J.M., Quick M.W. Relationship between nicotinic acetylcholine receptor subunit mRNA levels and channel function in central neurons. Soc. Neurosci. Abstr. 24:1998;1342.
170. Levitan I.B. Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu. Rev. Physiol. 56:1994;193-212.
171. Li L., Schuchard M., Palma A., Pradier L., McNamee M.G. Functional role of the cysteine 451 thiol group in the M4 helix of the γ subunit of Torpedo californica acetylcholine receptor. Biochemistry. 29:1990;5428-5436.
172. Li L., Lee Y.-H., Pappone P., Palma A., McNamee M.G. Site-specific mutations of nicotinic acetylcholine receptor at the lipid-protein interface dramatically alter ion channel gating. Biophys. J. 62:1992;61-63.
173. Lindstrom J. Probing nicotinic acetylcholine receptors with monoclonal antibodies. Trends Neurosci. 9:1986;401-407.
174. Lo D.C., Pinkham J.L., Stevens C.F. Role of a key cysteine residue in the gating of the acetylcholine receptor. Neuron. 6:1991;31-40.
175. Lopez M.G., Montiel C., Herrero C.J., Garcia-Palomero E., Mayorgas Y., Hernandez-Guijo J.M., et al. Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers. Proc. Natl. Acad. Sci. USA. 95:1998;14184-14189.
176. Loughnan M., Bond T., Atkins A., Cuevas J., Adams D.J., Broxton N.M., et al. α-Conotoxin EpI, a novel sulfated peptide from Conus episcopatus that selectively targets neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 273:1998;15667-15674.
177. Luetje C.W., Piattoni M., Patrick J. Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric α subunits. Mol. Pharmacol. 44:1993;657-666.
178. Lukas R.J., Morimoto H., Hanley M.R., Bennett E. Radiolabeled α-bungarotoxin derivatives: kinetic interaction with nicotinic acetylcholine receptors. Biochemistry. 20:1981;7373-7378.
179. Luo S., Kulak J.M., Cartier G.E., Jacobsen R.B., Yoshikami D., Olivera B.M., McIntosh J.M. α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18:1998;8571-8579.
180. Machold J., Utkin Y., Kirsch D., Kaufmann R., Tsetlin V., Hucho F. Photolabeling reveals the proximity of the α-neurotoxin binding site to the M2 helix of the ion channel in the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA. 92:1995;7282-7286.
181. Machold J., Weise C., Utkin Y.N., Franke P., Tsetlin V.I., Hucho F. A new class of photoactivatable and cleavable derivatives of neurotoxin II from Naja naja oxiana. Synthesis, characterisation, and application for affinity labelling of the nicotinic acetylcholine receptor from Torpedo californica. Eur. J. Biochem. 228:1995;947-954.
182. Machold J., Weise C., Utkin Y.N., Franke P., Tsetlin V.I., Hucho F. The handedness of the subunit arrangement of the nicotinic acetylcholine receptor from Torpedo californica. Eur. J. Biochem. 234:1995;427-430.
183. Maelicke A., Alburquerque E.X. New approach to drug therapy in Alzheimer's dementia. Drug Disc Today. 1:1996;53-59.
184. Maelicke A., Coban T., Storch A., Schrattenholz A., Pereira E.F.R., Alburquerque E.X. Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists. J. Rec. Signal Transd. Res. 17:1997;11-28.
185. Maelicke A., Schrattenholz A., Schröder B. Modulatory control by noncompetitive agonists of nicotinic cholinergic neurotransmission in the central nervous system. Semin. Neurosci. 7:1995;103-114.
186. Maelicke A., Schrattenholz A., Storch A., Schröder B., Gutbrod O., Methfessel C., et al. Noncompetitive agonism at nicotinic acetylcholine receptor. Functional signficance for CNS signal transduction. J. Rec. Sign. Transd. Res. 15:1995;333-353.
187. Martin M., Czajkowski C., Karlin A. The contributions of aspartyl residues in the acetylcholine receptor γ and δ subunits to the binding of agonists and competitive antagonists. J. Biol. Chem. 271:1996;13497-13503.
188. Martin M., Karlin A. Functional effects on the acetylcholine receptor of multiple mutations of γAsp174 and δAsp180. Biochemistry. 36:1997;10742-10750.
189. Martínez J.S., Olivera B., Gray W.R., Craig A.G., Groebe D.R., Abramson S.N., McIntosh J.M. α-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. Biochemistry. 34:1995;14519-14526.
190. Maslennikov I.V., Sobol A.G., Gladky K.V., Lugovskoy A.A., Ostrovsky A.G., Tsetlin V.I., et al. Two distinct structures of α-conotoxin GI in aqueous solution. Eur. J. Biochem. 254:1998;238-247.
191. Maslennikov I.V., Shenkarev Z.O., Zhmak M.N., Ivanov V.T., Methfessel C., Tsetlin V.I., Arseniev A.S. NMR spatial structure of α-conotoxin ImI reveals a common scaffold in snail and snake toxins recognizing neuronal nicotinic acetylcholine receptors. FEBS Lett. 444:1999;275-280.
192. Matsubayashi H., Alkondon M., Pereira E.F.R., Swanson K.L., Alburquerque E.X. Strychnine. A potent competitive antagonist of α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons. J. Pharm. Exp. Ther. 284:1998;904-913.
193. McArdle J.J., Lentz T.L., Witzemann V., Schwarz H., Weinstein S.A., Schmidt J.J. Waglerin-1 selectively blocks the ε-form of the muscle nicotinic acetylcholine receptor. J. Pharm. Exp. Ther. 289:1999;543-550.
194. McBain C.J., Mayer M.L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74:1994;723-760.
195. A receptor channels. Ion Chann. 3:1992;315-343.
196. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
197. McIntosh J.M., Yoshikami D., Mahe E., Nielsen D.B., Rivier J.E., Gray W.R., Olivera B.M. A nicotinic acetylcholine receptor ligand of unique specificity, α-conotoxin ImI. J. Biol. Chem. 269:1994;16733-16739.
198. McLane K.E., Tang F., Conti-Tronconi B.M. Localization of sequence segments forming a kappa-bungarotoxin-binding site on the α3 neuronal nicotinic receptor. J. Biol. Chem. 265:1990;1537-1544.
199. McLane K.E., Wu X., Conti-Tronconi B.M. An α-bungarotoxin-binding sequence on the Torpedo nicotinic acetylcholine receptor α-subunit: Conservative amino acids substitutions reveal side-chain specific interactions. Biochemistry. 33:1994;2576-2585.
200. McLaughlin J.T., Hawrot E., Yellen G. Covalent modification of engineered cysteines in the nicotinic acetylcholine receptor agonist-binding domain inhibits receptor activation. Biochem. J. 310:1995;765-769.
201. 3H]nicotine as an agonist photoaffinity label. Biochemistry. 30:1991;6987-6997.
202. Mishina M., Tobimatsu T., Imoto K., Tanaka K., Fujita Y., Fukuda K., et al. Location of functional regions of acetylcholine receptor α-subunit by site-directed mutagenesis. Nature. 313:1985;364-369.
203. Mochly-Rosen D., Fuchs S. Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site. Biochemistry. 20:1981;5920-5924.
204. Moore H.P., Raftery M.A. Studies of reversible and irreversible interactions of an alkylating agonist with Torpedo californica acetylcholine receptor in membrane-bound and purified states. Biochemistry. 18:1979;1907-1911.
205. Mulle C., Léna C., Changeux J.-P. Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron. 8:1992;937-945.
206. Myers R.A., Cruz L.J., Rivier J.E., Olivera B.M. Conus peptides as chemical probes for receptors and ion channels. Chem. Rev. 93:1993;1923-1936.
207. Myers R.A., Zafaralla G.C., Gray W.R., Abbott J., Cruz L.J., Olivera B.M. α-Conotoxin, small peptide probes of nicotinic acetylcholine receptor. Biochemistry. 30:1991;9370-9377.
208. Nakazawa K., Ohno Y. Block by 5-hydroxytryptamine and apomorphine of recombinant human neuronal nicotinic receptors. Eur. J. Pharmacol. 374:1999;293-299.
209. Nathanson N.M., Hall Z.W. In situ labeling of Torpedo and rat muscle acetylcholine receptor by a photoaffinity derivative of α-bungarotoxin. J. Biol. Chem. 255:1980;1698-1703.
210. A receptor determined by electron microscopic image analysis. J. Neurochem. 62:1994;815-818.
211. Neumann D., Barchan D., Fridkin M., Fuchs S. Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor α subunit. Proc. Natl. Acad. Sci. USA. 83:1986;9250-9253.
212. Newbolt A., Stoop R., Virginio C., Suprenant A., North R.A., Buell G., Rassendren F. Membrane topology of an ATP-gated ion channel (P2X receptor). J. Biol. Chem. 273:1998;15177-15782.
213. Nicke A., Baumert H.G., Rettinger J., Eichele A., Lambrecht G., Mutschler E., Schmalzing G. P2X1 and P2X2 receptors form stable trimers: a novel structural motif of ligand-gated channels. EMBO J. 17:1998;3016-3028.
214. Nowak M.W., Kearney P.C., Sampson J.R., Saks M.E., Labarca C.G., Silverman S.K., et al. Nicotinic receptor binding site probed with unnatural amino acid incorporation in intact cells. Science. 268:1995;439-442.
215. Ohana B., Gershoni J.M. Comparison of the toxin binding sites of the nicotinic acetylcholine receptor from Drosophila to human. Biochemistry. 29:1990;6409-6415.
216. Ohno K., Wang H.-L., Milone M., Bren N., Brengman J.M., Nakano S., et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron. 17:1996;157-170.
217. Okonjo K.O., Kuhlmann J., Maelicke A. A second pathway for the activation of the Torpedo actylcholine receptor. Eur. J. Biochem. 200:1991;671-677.
218. O'Leary M.E., Filatov G.N., White M.M. Characterization of d-tubocurarine binding site of Torpedo acetylcholine receptor. Am. J. Physiol. 266:1994;C648-C653.
219. O'Leary M.E., White M.M. Mutational analysis of ligand-induced activation of the Torpedo acetylcholine receptor. J. Biol. Chem. 267:1992;8360-8365.
220. Olivera B.M., Rivier J., Clark C., Corpuz G.P., Mena E., Ramilo C.A., Cruz L.J. Diversity of Conus neuropeptides. Science. 249:1990;257-263.
221. Ortells M.O., Lunt G.G. Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 18:1995;121-127.
222. Osaka H., Malany S., Kanter J.R., Sine M.S., Taylor P. Subunit interface selectivity of the α-neurotoxins for the nicotinic acetylcholine receptor. J. Biol. Chem. 274:1999;9581-9586.
223. Osaka H., Sugiyama N., Taylor P. Distinctions in agonist and antagonist specificity conferred by anionic residues of the nicotinic acetylcholine receptor. J. Biol. Chem. 273:1998;12758-12765.
224. Oswald R.E., Changeux J.-P. Crosslinking of alpha-bungarotoxin to the acetylcholine receptor from Torpedo marmorata by ultraviolet light irradiation. FEBS Lett. 139:1982;225-229.
225. Paas Y. The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neurosci. 21:1998;117-125.
226. Paas Y., Eisenstein M., Medevielle F., Teichberg V.I., Devillers-Thiéry A. Identification of the amino acid subsets accounting for the ligand binding specificity of a glutamate receptor. Neuron. 17:1996;979-990.
227. Palma E., Bertrand S., Binzoni T., Bertrand D. Neuronal nicotinic α7 receptor expressed in Xenopus oocytes present five putative binding sites for methyllycaconitine. J. Physiol. 491.1:1996;151-161.
228. Palma A., Maggi L., Eusebi F., Miledi R. Neuronal nicotinic threonine-for-leucine 247 α7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine. Proc. Natl. Acad. Sci. USA. 94:1997;9915-9919.
229. Palma A., Mileo A.M., Eusebi F., Miledi R. Threonine-for-leucine mutation within domain M2 of the neuronal α7 nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. Proc. Natl. Acad. Sci. USA. 93:1996;11231-11235.
230. Papke R.L., Duvoisin R.M., Heinemann S.F. The amino terminal half of the nicotinic β-subunit extracellular domain regulates the kinetic of inhibition by neuronal bungarotoxin. Proc. R. Soc. London Biol. 252:1993;141-148.
231. Pascual J.M., Karlin A. State-dependent accessibility and electrostatic potential in the channel of the acetylcholine receptor. Inferences from rates of reaction of thiosulfonates with substituted cysteines in the M2 segment of the α subunit. J. Gen. Physiol. 111:1998;717-739.
232. Pascuzzo G.J., Akaide A., Maleque M.A., Shaw K.-P., Aronstam R.S., Rickett D.L., Alburquerque E.X. The nature of the interaction of pyridostigmine with the nicotinic acetylcholine receptor-ion channel complex in rat myotubes. Mol. Pharmacol. 25:1984;92-101.
233. Pearce S.F., Hawrot E. Intrinsic fluorescence of binding-site fragments of the nicotinic acetylcholine receptor: perturbations produced upon binding α-bungarotoxin. Biochemistry. 29:1990;10649-10659.
234. Pedersen S.E. Site-selective photoaffinity-labeling of the Torpedo californica nicotinic acetylcholine receptor by azide derivatives of ethidium bromide. Mol. Pharmacol. 47:1995;1-9.
235. Pedersen S.E., Cohen J.B. d-Tubocurarine binding sites are located at α-γ and α-δ subunit interfaces of the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA. 87:1990;2785-2789.
236. Pedersen S.E., Papineni R.V.L. Interaction of d-tubocurarine anlogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site. J. Biol. Chem. 270:1995;31141-31150.
237. 3H]Meproadifen mustard reacts selectively with α-subunit Glu-262. J. Biol. Chem. 267:1992;10489-10499.
238. Pereira E.F., Alkondon M., McIntosh J.M., Alburquerque E.X. α-Conotoxin ImI: a competitive antagonist at α-bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons. J. Pharmacol. Exp. Ther. 278:1996;1472-1483.
239. Pereira E.F.R., Alkondon M., Reinhardt S., Maelicke A., Peng X., Lindstrom J., et al. Physostigmine and galanthamine: Probes for a novel binding site on the α4β2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells. J. Pharmacol. Exp. Ther. 270:1994;768-778.
240. Pereira E.F.R., Alkondon M., Tano T., Castro N.G., Fróes-Ferrão M.M., Rozental R., et al. A novel agonist binding site on nicotinic acetylcholine receptors. J. Rec. Res. 13:1993;413-436.
241. Phillips W.D., Maimone M.M., Merlie J.P. Mutagenesis of the 43-kDa postsynaptic protein defines domains involved in plasma membrne targeting and AChR clustering. J. Cell. Biol. 115:1991;1713-1723.
242. Picciotto M.R., Zoli M., Léna C., Bessis A., Lallemand Y., LeNovére N., et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 374:1995;65-67.
243. Picciotto M.R., Zoli M., Zachariou V., Changeux J.-P. Contribution of nicotine acetylcholine receptors containing the β2-subunit to the behavioural effects of nicotine. Biochem. Soc. Trans. 25:1997;824-829.
244. Pillet L., Trémeau O., Ducancel F., Drevet P., Zinn-Justin S., Pinkasfeld S., et al. Genetic engineering of snake toxins. Role of invariant residues in the structural and functinal properties of a curaremimetic toxin, as probed by site-directed mutagenesis. J. Biol. Chem. 268:1993;909-916.
245. Pradier L., Yee A., McNamee M.G. Use of chemical modifications and site-directed mutagenesis to probe the functional role of thiol groups on the γ subunit of Torpedo californica acetylcholine receptor. Biochemistry. 28:1989;6562-6571.
246. Preston-Hurlburt P., Wilson P.T., Dowding A.J., Hawrot E. Monoclonal antibodies directed against a synthetic peptide corresponding to the α-bungarotoxin binding region of the acetylcholine receptor. Biochim. Biophys. Acta. 1033:1990;324-328.
247. Prince R.J., Sine S.M. Molecular dissection of subunit interfaces in the acetylcholine receptor. Identification of residues that determine agonist selectivity. J. Biol. Chem. 271:1996;25770-25777.
248. Prince R.J., Sine S.M. Epibatidine binds with unique site and state selectivity to muscle nicotinic acetylcholine receptors. J. Biol. Chem. 273:1998;7843-7849.
249. Prince R.J., Sine S.M. The ligand binding domains of nicotinic acetylcholine receptor. Barrantes F.J. The Nicotinic Acetylcholine Receptor: Current Views and Future Trends. 1998;31-59 Landes Bioscience, Austin, TX.
250. Quiram P.A., Sine S.M. Identification of residues in the neuronal α7 acetylcholine receptor that confer selectivity for conotoxin ImI. J. Biol. Chem. 273:1998;11001-11006.
251. Quiram P.A., Sine S.M. Structural elements in α-conotoxin ImI essential for binding to neuronal α7 receptors. J. Biol. Chem. 273:1998;11007-11011.
252. Rajendra S., Lynch J.W., Pierce K.D., French C.R., Barry P.H., Schofield P.R. Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonists. Neuron. 14:1995;169-175.
253. Rajendra S., Vandenberg R.J., Pierce K.D., Cunninham A.M., French P.W., Barry P.H., Schofield P.R. The unique extracellular disulfide loop of the glycine receptor is a principal ligand binding element. EMBO J. 14:1995;2987-2998.
254. Ramilo C.A., Zafaralla G., Nadasdi L., Hammerland L.G., Yoshikami D., Gray W.R., et al. Novel α- and ω-conotoxins from Conus striatus venom. Biochemistry. 31:1992;9919-9926.
255. Role L.W. Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr. Opin. Neurobiol. 2:1992;254-262.
256. 3H]cytisine binding to immunoisolated nicotinic acetylcholine receptors from chick brain containing α4β2 subunits. J. Neurochem. 62:1994;1368-1374.
257. Rothlin C.V., Katz E., Verbitsky M., Elgoyhen A.B. The α9 nicotinic acetylcholine receptor shares pharmacological properties with type A γ-aminobutyric acid, glycine, and type 3 serotonin receptors. Mol. Pharmacol. 55:1999;248-254.
258. Rousselet A., Faure G., Boulain J.-C., Ménez A. The interaction of neurotoxin derivatives with either acetylcholine receptor or as monoclonal antibody. An electron-spin-resonance study. Eur. J. Biochem. 140:1984;31-37.
259. Ruan K.-H., Stiles B., Atassi M.Z. The short-neurotoxin-binding regions on the α-chain of human and Torpedo californica acetylcholine receptors. Biochem. J. 274:1991;849-854.
260. Rübsamen H., Eldefrawi A.T., Eldefrawi M.E., Hess G. Characterization of the calcium-binding sites of the purified acetylcholine receptor and identification of the calcium binding site subunit. Biochemistry. 17:1978;3818-3825.
261. Scherf T., Balass M., Fuchs S., Katchalski-Katzir E., Anglister J. Three-dimensional solution structure of the complex of α-bungarotoxin with a library-derived peptide. Proc. Natl. Acad. Sci. USA. 94:1997;6059-6064.
262. Schrattenholz A., Coban T., Schröder B., Okonjo K.O., Kuhlmann J., Pereira E.F., et al. Biochemical characterization of a novel channel-activating site on nicotinic acetylcholine receptors. J. Rec. Res. 13:1993;393-412.
263. Schrattenholz A., Godovac-Zimmerman J., Schäfer H.-J., Alburquerque E.X., Maelicke A. Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine. Eur. J. Biochem. 216:1993;671-677.
264. Schrattenholz A., Pereira E.F.R., Roth U., Weber K.-H., Alburquerque E.X., Maelicke A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49:1996;1-6.
265. Schröder B., Reinhardt-Maelicke S., Schrattenholz A., McLane K.E., Kretschmer A., Conti-Tronconi B.M., Maelicke A. Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo actylcholine receptor α-polypeptide. J. Biol. Chem. 269:1994;10407-10416.
266. 3 receptors. Society Neurosci. Abstr. 21:1995;30.6.
267. Seifert S.A., Eldefrawi M.E. Affinity of myasthenia drugs to acetylcholinesterase and acetylcholine receptor. Biochem. Med. 18:1974;258-265.
268. Sellin L.C., Mattila K., Annila A., Schmidt J.J., McArdle J.J., Hyvönen M., et al. Conformational analysis of a toxic peptide from Trimeresurus wagleri which blocks the nicotinic acetylcholine receptor. Biophys. J. 70:1996;3-13.
269. Servent D., Ménez A., Kessler P. Site-directed disulfide reduction using an affinity reagent: application on the nicotinic acetylcholine receptor. FEBS Lett. 360:1995;261-265.
270. Servent D., Mourier G., Antil S., Ménez A. Curaremimetic toxins discriminate between nicotinic acetylcholine receptor subtypes. Toxicol. Lett. 103:1998;199-203.
271. Sgard F., Fraser S.P., Katkowska M.J., Djamgoz M.B.A., Dunbar S.J., Windass J.D. Cloning and functional characterisation of two novel nicotinic acetylcholine receptor α subunits from the insect pest Myzus persicae. J. Neurochem. 71:1998;903-912.
272. Shaw K.-P., Aracava Y., Akaike A., Daly J.W., Rickett D.L., Alburquerque E.X. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol. Pharmacol. 28:1985;527-538.
273. 2 neuronal nicotinic acetylcholine receptor-targeted ligand. Biochemistry. 36:1997;15693-15700.
274. A receptor subtypes. Pharmacol. Rev. 47:1995;181-234.
275. A receptor channels. EMBO J. 11:1992;2017-2023.
276. Sine S.M. Molecular dissection of subunit interfaces in the acetylcholine receptor: Identification of residues that determine curare selectivity. Proc. Natl. Acad. Sci. USA. 90:1993;9436-9440.
277. Sine S.M. Identification of equivalent residues in the γ, δ, and ε subunit of the nicotinic acetylcholine receptor that contribute to α-bugarotoxin binding. J. Biol. Chem. 272:1997;23521-23527.
278. Sine S.M., Bren N., Quiram P.A. Molecular dissection of subunit interfaces in the nicotinic acetylcholine receptor. J. Physiol. 92:1998;101-105.
279. Sine S.M., Claudio T. γ- and δ-subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor. J. Biol. Chem. 266:1991;19369-19377.
280. Sine S.M., Claudio T., Sigworth F.J. Activation of Torpedo acetylcholine receptors expressed in mouse fibroblasts. Single channel current kinetics reveal distinct agonist binding affinities. J. Gen. Physiol. 96:1990;395-437.
281. Sine S.M., Kreienkamp H.-J., Bren N., Maeda R., Taylor P. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of α-conotoxin M1 selectivity. Neuron. 15:1995;205-211.
282. Sine S.M., Ohno K., Bouzat C., Auerbach A., Milone M., Pruitt J.N., Engel A.G. Mutation of the actylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron. 15:1995;229-239.
283. Sine S.M., Quiram P., Papanikolaou F., Kreienkamp H.-J., Taylor P. Conserved tyrosines in the α subunit of the nicotinic acetylcholine receptor stabilize quaternary ammonium groups of agonists and curariform antagonists. J. Biol. Chem. 269:1994;8808-8816.
284. Sobel A., Heidmann T., Cartaud J., Changeux J.-P. Reconstitution of a functional acetylcholine receptor. Polypeptide chains, ultrastructure and binding sites for acetylcholine and local anesthetics. Eur. J. Biochem. 110:1980;13-33.
285. Spivak C.E. Correlations among Hill parameters reflect models of activating ligand-gated ion channels. Trends Pharmacol. Sci. 16:1995;39-42.
286. Spura A., Russin T.S., Freedman N.D., Grant M., McLaughlin J.T., Hawrot E. Probing the agonist domain of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis reveals residues in proximity to the α-bungarotoxin binding site. Biochemistry. 38:1999;4912-4921.
287. Stauffer D.A., Karlin A. Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. Biochemistry. 33:1994;6840-6849.
288. Starter M. Taking stock of cognition enhancers. Trends Pharmacol. Sci. 12:1991;456-461.
289. Storch A., Schrattenholz A., Cooper J.C., Ghani E.M.A., Gutbrod O., Weber K.-H., et al. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells. Eur. J. Pharmacol. 290:1995;207-219.
290. Stroud R.M., McCarthy M.P., Shuster M. Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels. Biochemistry. 29:1990;11009-11023.
291. Sugiyama N., Boyd A.E., Taylor P. Anionic residue in the α-subunit of the nicotinic acetylcholine receptor contributing to subunit assembly and ligand binding. J. Biol. Chem. 271:1996;26575-26581.
292. Sugiyama N., Marchot P., Kawanishi C., Osaka H., Molles B., Sine S.M., Taylor P. Residues at the subunit interfaces of the nicotinic acetylcholine receptor that contribute to α-conotoxin M1 binding. Mol. Pharmacol. 53:1998;787-794.
293. Sung J.J., Kim S.J., Lee H.B., Chung J.M., Choi Y.M., Cha C.I., et al. Anticholinesterase induces nicotinic receptor modulation. Musc. Nerv. 21:1998;1135-1144.
294. Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., Silman I. Atomic structure of acetylcholinesterase from Torpedo californica. Science. 253:1991;872-879.
295. Svensson A.-L., Nordberg A. Tacrine interacts with an allosteric site on α4β2 nAChRs in M10 cells. NeuroReport. 7:1996;2201-2205.
296. Swope S.L., Moss S.J., Blackstone C.D., Huganir R.L. Phosphorylation of ligand-gated ion channels: a possible mode of synaptic plasticity. FASEB J. 6:1992;2514-2523.
297. Tamamizu S., Butler D.H., Lasalde J.A., McNamee M.G. Effects of antibody binding on structural transitions of the nicotinic acetylcholine receptor. Biochemistry. 35:1996;11773-11781.
298. Tavazoie S.F., Tavazoie M.F., McIntosh J.M., Olivera B.M., Yoshikami D. Differential block of nicotinic synapses on B versus C neurons in sympathetic ganglia of frog by α-conotoxins MII and ImI. Br. J. Pharmacol. 120:1996;995-1000.
299. Taylor P., Osaka H., Molles B.E., Sugiyama N., Marchot P., Ackermann E.J., et al. Toxins selective for subunit interafces as probes of nicotinic acetylcholine receptor structure. J. Physiol. 92:1998;79-83.
300. Thal L.J., Fuld P.A., Masur D.M., Sharpless N.S. Oral physostigmine and lecithin improve memory in Alzheimer's disease. Ann. Neurol. 13:1983;491-496.
301. Tine S.-J., Raftery M.A. Photoaffinity labeling of Torpedo acetylcholine receptor at multiple sites. Proc. Natl. Acad. Sci. USA. 90:1993;7308-7311.
302. Tomaselli G.F., McLaughlin J.T., Jurman M.E., Hawrot E., Yellen G. Mutations affecting agonist sensitivity of the nicotinic acetylcholine receptor. Biophys. J. 60:1991;721-727.
303. 125) Azidonicotinoid ptotoaffinity labeling of insecticide-binding subunit of Drosophila nicotinic acetylcholine receptor. Neurosci. Lett. 237:1997;61-64.
304. Toyoshima C., Unwin P.N.T. Three-dimensional structure of the acetylcholine receptor by cryoelectron microscopy and helical image reconstruction. J. Cell. Biol. 111:1990;2623-2635.
305. Trémeau O., Lemaire C., Drevet P., Pinkasfeld S., Ducancel F., Boulain J.-C., Ménez A. Genetic engineering of snake toxins. The functional site of erabutoxin a, as delineated by site-directed mutagenesis, includes variant residues. J. Biol. Chem. 270:1995;9362-9369.
306. Tsigelny I., Sugiyama N., Sine S.M., Taylor P. A model of the nicotinic receptor extracellular domain based on sequence identity and residue location. Biophys. J. 73:1997;52-66.
307. Tzartos S.J., Remoundos M.S. Fine localization of the major α-bungarotoxin binding site to residues α189-195 of the Torpedo acetylcholine receptor: residues 189, 190, and 195 are indispensable for binding. J. Biol. Chem. 265:1990;21462-21467.
308. Ullian E.M., McIntosh J.M., Sargent P.B. Rapid synaptic transmission in the avian ciliary ganglion is mediated by two distinct classes of nicotinic receptors. J. Neurosci. 17:1997;7210-7219.
309. Unwin N. Nicotinic acetycholine receptor at 9 Å resolution. J. Mol. Biol. 229:1993;1101-1124.
310. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature. 373:1995;37-43.
311. Unwin N. Projection structure of the nicotinic acetylcholine receptor. Distinct conformations of the α-subunit. J. Mol. Biol. 257:1996;586-596.
312. Utkin Y.N., Kobayashi Y., Hucho F., Tsetlin V.I. Relationship between the binding sites for α-conotoxin and snake venom neurotoxins in the nicotinic acetylcholine receptor from Torpedo californica. Toxicon. 32:1994;1153-1157.
313. Utkin Y.N., Krivoshein A.V., Davydov V.L., Kasheverov I.E., Franke P., Maslennikov I.V., et al. Labeling of Torpedo californica nicotinic acetylcholine receptor subunits by cobratoxin derivatives with photoactivatable groups of different chemical nature at Lys23. Eur. J. Biochem. 253:1998;229-235.
314. Utkin Y.N., Weise C., Tritscher E., Machold J., Franke P., Tsetlin V.I., Hucho F. Structure determination of peptide fragments from the cross-linked complex of Lys26-p-azidobenzoyl neurotoxin II from Naja naja oxiana with the nicotinic acetylcholine receptor from Torpedo californica. Bioorganicheskaya Khimiya. 20:1994;1047-1059.
315. Valenzuela C.F., Dowding A.J., Arias H.R., Johnson D.A. Antibody-induced conformational changes in the Torpedo nicotinic acetylcholine receptor: A fluorescence study. Biochemistry. 33:1994;6586-6594.
316. Valenzuela C.F., Weign P., Yguerabide J., Johnson D.A. Transverse distance between the membrane and the agonist binding sites on the Torpedo acetylcholine receptor: a fluorescence study. Biophys. J. 66:1994;674-682.
317. Van den Beukel Y., Van Kleef R.G.D.M., Zwart R., Oortgiesen M. Physostigmine and acetylcholine differentially activate nicotinic receptor subpopulations in Locusta migratoria neurons. Brain Res. 789:1998;263-273.
318. 2+ pemeable ion channels. Proc. Natl. Acad. Sci. USA. 95:1997;11456-11461.
319. Vazquez R.W., Oswald R.E. Identification of a new amino acid residue capable of modulating agonist efficacy at the homomeric nicotinic acetylcholine receptor, α7. Mol. Pharmacol. 55:1999;1-7.
320. Venera G.D., Testai F.D., Pena C., Lacorazza H.D., Bonino M.J.B.D. Involvement of Histidine-134 in the binding of α-bungarotoxin to the nicotinic acetylcholine receptor. Neurochem. Int. 31:1997;151-157.
321. Verrall S., Hall Z.W. The N-terminal domain of acetylcholine receptor subunits contain recognition signals for the initial steps of receptor assembly. Cell. 68:1992;23-31.
322. 2+ channels of chromaffin cells. Eur. J. Pharmacol. 320:1997;249-257.
323. Vincent A., Newland C., Croxen R., Beeson D. Genes at the junction - candidates for congenital myasthenic syndromes. Trends Neurosci. 20:1997;15-22.
324. Virginio C., MacKenzie A., Rassendren F.A., North R.A., Surprenant A. Pore dilation of neuronal P2X receptor channels. Nature Neurosci. 2:1999;315-321.
325. Wahlsten J.L., Lindstrom J.M., Conti-Tronconi B.M. Amino acid residues within the sequence region α55-74 of Torpedo nicotinic acetylcholine
326. Walker J.W., Richardson C.A., McNamee M.G. Effects of thiol group modifications of Torpedo californica acetylcholine receptor ion flux activation and inactivation kinetics. Biochemistry. 23:1984;2329-2338.
327. Walkinshaw M.D., Saenger W., Maelicke A. Three-dimensional structure of the 'long' neurotoxin from cobra venom. Proc. Natl. Acad. Sci. USA. 77:1980;2400-2404.
328. Wang D., Xie Y., Cohen J.B. Probing the structure of the nicotinic acetylcholine receptor (nAChR) with 4-benzoylbenzoylcholine (Bz2-choline), a novel photoaffinity competitive antagonist. Biophys. J. 70:1996;A76. Abst.
329. Watters D., Maelicke A. Organization of ligand binding sites at the acetylcholine receptor: A study with monoclonal antibodies. Biochemistry. 22:1983;1811-1819.
330. Wheeler S.V., Chad J.E., Foreman R. Residues 1 to 80 of the N-terminal domain of the β subunit confer neuronal bungarotoxin sensitivity and agonist selectivity on neuronal nicotinic receptors. FEBS Lett. 332:1993;139-142.
331. Williamson P.T.F., Gröbner G., Spooner P.J.R., Miller K.W., Watts A. Probing the agonist binding pocket in the nicotinic acetylcholine receptor: A high-resolution solid-state NMR approach. Biochemistry. 37:1998;10854-10859.
332. Wilson G.G., Karlin A. The location of the gate in the acetylcholine receptor channel. Neuron. 20:1998;1269-1281.
333. Witzemann V., Raftery M.A. Selective photoaffinity labeling of acetylcholine receptor using a cholinergic analogue. Biochemistry. 16:1977;5862-5868.
334. Wu T.I., Liu C.I., Chang Y.C. A study of the oligomeric state of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring glutamate receptors in the synaptic junction of porcine brain. Biochem. J. 319:1996;731-739.
335. 3 receptor. Neuropharmacol. 37:1998;251-257.
336. 3 receptor. J. Biol. Chem. 274:1999;5537-5541.
337. Yguerabide J. Theory for establishing proximity relations in biological membranes by excitation energy transfer measurements. Biophys. J. 66:1994;683-693.
338. Zafaralla G.C., Ramilo C., Gray W.R., Karlstrom R., Olivera B.M., Cruz L.J. Phylogenetic specificity of cholinergic ligands: α-conotoxin SI. Biochemistry. 27:1988;7102-7105.
339. Zhang Y., Chen J., Auerbach A. Activation of recombinant mouse acetylcholine receptors by acetylcholine, carbamylcholine and tetramethylammonium. J. Physiol. 486:1995;189-206.